FOP News - IFOPA - International Fibrodysplasia Ossificans Progressiva Association

FOP News

18 FOP and HO Sessions and Posters Featured at the ASBMR 2022 Annual Meeting

Posted by · September 24, 2022 3:29 PM

Read more Share

BioCryst Pharmaceuticals Granted Orphan Drug Designation from U.S. FDA for BCX9250

Posted by · September 01, 2022 9:04 AM

Read more Share

You’re Invited to Submit Written Testimony to the US FDA

Posted by · August 24, 2022 10:06 AM

Read more Share

Ipsen's Resubmission to the US Food & Drug Administration is Accepted

Posted by · June 29, 2022 6:50 AM

Read more Share

BioCryst Pharmaceuticals Receives Fast Track Designation from U.S. FDA for BCX9250

Posted by · June 22, 2022 11:39 AM

Read more Share

Important Updates in FOP Clinical Trials

Posted by · June 21, 2022 1:23 PM

Read more Share

Updated Coronavirus (COVID-19) Precautions & Guidance for FOP Patients & Families

Posted by · June 06, 2022 1:26 PM

Read more Share

Regeneron Pharmaceuticals OPTIMA Trial Posted on ClinicalTrials.gov

Posted by · June 01, 2022 11:57 AM

Read more Share

Ipsen's Palovarotene Receives Regulatory Approval from Health Canada

Posted by · January 26, 2022 12:24 PM

Read more Share

Incyte Pharmaceuticals Has Submitted Their FOP Trial to ClinicalTrials.gov

Posted by · November 12, 2021 2:34 PM

Read more Share

«
1
2
3
4
5
6
7
8
9
10
11
»

Learn More

Is it FOP? Just Diagnosed Registry

Make a Difference

Donate Connect Fundraise

Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter